Scale/Scope:
2 districts
Evaluation Design:
Repeated cross-sectional – baseline: 14,952 recently delivered women (8,756 intervention, 6,196 control); endline: 13,826 recently delivered women (7,812 intervention, 6,014 control)
Outcomes
Outcomes Measured:
% of women who consumed equal to or more than 100 IFA tablets during pregnancy
Results:
Endline vs. baseline:
Intervention group: 21.3% vs. 5%
Control group: 8.3% vs. 6.7%
Intervention group: 21.3% vs. 5%
Control group: 8.3% vs. 6.7%
P-values/CIs:
p<0.00110
Height
Tallest
High Impact Practices:
Intake of micronutrient and iron supplements